Healthcare provider profile · identity verified

Casey L Cochran, DO

Family Practice · ENID, OK · NPI 1821433681

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	329	69
Atorvastatin Calcium	Atorvastatin Calcium	305	76
Pantoprazole Sodium	Pantoprazole Sodium	252	64
Levothyroxine Sodium	Levothyroxine Sodium	233	59
Amlodipine Besylate	Amlodipine Besylate	221	61
Losartan Potassium	Losartan Potassium	215	59
Metformin Hcl	Metformin Hcl	187	42
Rosuvastatin Calcium	Rosuvastatin Calcium	182	49
Lisinopril	Lisinopril	177	49
Omeprazole	Omeprazole	157	40
Meloxicam	Meloxicam	144	34
Hydrochlorothiazide	Hydrochlorothiazide	143	37
Fluticasone Propionate	Fluticasone Propionate	138	61
Simvastatin	Simvastatin	137	42
Trazodone Hcl	Trazodone Hcl	132	30
Trulicity	Dulaglutide	124	13
Metoprolol Succinate	Metoprolol Succinate	122	34
Tamsulosin Hcl	Tamsulosin Hcl	116	33
Metoprolol Tartrate	Metoprolol Tartrate	111	21
Eliquis	Apixaban	105	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	103	27
Potassium Chloride	Potassium Chloride	102	29
Carvedilol	Carvedilol	99	24
Clopidogrel	Clopidogrel Bisulfate	99	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	96	14
Tramadol Hcl	Tramadol Hcl	96	28
Montelukast Sodium	Montelukast Sodium	93	26
Alprazolam	Alprazolam	88	17
Glipizide	Glipizide	86	19
Duloxetine Hcl	Duloxetine Hcl	85	16
Zolpidem Tartrate	Zolpidem Tartrate	76	15
Furosemide	Furosemide	74	25
Albuterol Sulfate Hfa	Albuterol Sulfate	72	29
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	68	13
Citalopram Hbr	Citalopram Hydrobromide	67	16
Allopurinol	Allopurinol	64	14
Ropinirole Hcl	Ropinirole Hcl	62	12
Sertraline Hcl	Sertraline Hcl	60	17
Celecoxib	Celecoxib	59	14
Azithromycin	Azithromycin	56	42
Farxiga	Dapagliflozin Propanediol	53	suppressed
Diclofenac Sodium	Diclofenac Sodium	50	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	49	12
Venlafaxine Hcl Er	Venlafaxine Hcl	47	suppressed
Tizanidine Hcl	Tizanidine Hcl	45	24
Tresiba Flextouch U-100	Insulin Degludec	43	suppressed
Valsartan	Valsartan	43	11
Aripiprazole	Aripiprazole	42	suppressed
Methylprednisolone	Methylprednisolone	41	35
Ozempic	Semaglutide	39	suppressed
Cephalexin	Cephalexin	38	31
Estradiol	Estradiol	38	suppressed
Pravastatin Sodium	Pravastatin Sodium	38	11
Xarelto	Rivaroxaban	37	suppressed
Jardiance	Empagliflozin	35	suppressed
Amoxicillin	Amoxicillin	34	26
Fluoxetine Hcl	Fluoxetine Hcl	32	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	31	suppressed
Glimepiride	Glimepiride	31	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	31	suppressed
Ventolin Hfa	Albuterol Sulfate	30	11
Hydralazine Hcl	Hydralazine Hcl	29	suppressed
Propranolol Hcl Er	Propranolol Hcl	29	suppressed
Glipizide Er	Glipizide	28	suppressed
Temazepam	Temazepam	28	suppressed
Finasteride	Finasteride	27	suppressed
Sucralfate	Sucralfate	27	suppressed
Ezetimibe	Ezetimibe	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Bupropion Xl	Bupropion Hcl	25	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Metformin Hcl Er	Metformin Hcl	24	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	23	suppressed
Buspirone Hcl	Buspirone Hcl	22	suppressed
Ondansetron Hcl	Ondansetron Hcl	22	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	20	suppressed
Benazepril Hcl	Benazepril Hcl	20	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	19	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	19	suppressed
Atenolol	Atenolol	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	18	suppressed
Oxycodone Hcl	Oxycodone Hcl	18	suppressed
Spironolactone	Spironolactone	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Terazosin Hcl	Terazosin Hcl	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	17	suppressed
Donepezil Hcl	Donepezil Hcl	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Nystatin	Nystatin	17	suppressed
Irbesartan	Irbesartan	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	16	suppressed
Prednisone	Prednisone	16	11
Hydroxyzine Hcl	Hydroxyzine Hcl	15	suppressed
Alendronate Sodium	Alendronate Sodium	14	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Fluconazole	Fluconazole	14	suppressed
Lubiprostone	Lubiprostone	14	suppressed
Naproxen	Naproxen	14	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	12
Desmopressin Acetate	Desmopressin Acetate	12	suppressed
Entresto	Sacubitril/Valsartan	12	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	12	suppressed
Mirtazapine	Mirtazapine	12	suppressed
Primidone	Primidone	12	suppressed
Silodosin	Silodosin	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Prempro	Estrogen,con/M-Progest Acet	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Torsemide	Torsemide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error